1281292 - 11759070 - 1

15 Most Shorted Stocks Right Now

Published on November 17, 2022 at 6:18 pm by Usman Kabir in Hedge Funds, News

In this article, we discuss the 15 most shorted stocks right now. If you want to read about some more shorted stocks, go directly to 5 Most Shorted Stocks Right Now.

The stock market has been volatile in the past few months as soaring inflation and rising rates combine to create an uncertain business environment in which growth stocks have taken a beating. Many elite investors who were bullish on growth firms at the beginning of this year have instead started shorting these growth stocks as recession fears rise. Even top firms like Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Meta Platforms, Inc. (NASDAQ:FB) have underperformed under these pressures.

However, recent data by the US government suggests that inflation may be peaking and it might be the right time to buy the dip on some of these growth firms or to initiate a short squeeze on the shorted stocks. Per latest figures, the consumer price index rose just 0.4% for the month in October, representing an increase of 7.7% from a year ago, the lowest annual increase since January and a slowdown from the 8.2% annual pace in the prior month. Top economists had been expecting increases of 0.6% and 7.9%.

Our Methodology

The companies that have a short interest of more than 20% were selected for the list. The short interest of each stock was taken from Yahoo Finance.

Most Shorted Stocks Right Now

15. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

Number of Hedge Fund Holders: 17

Short Interest as of November 15: 37.57%

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a clinical stage immuno-oncology company that develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It is one of the most shorted stocks right now. It recently posted earnings for the third quarter of 2022, reporting a revenue of $0.05, beating market estimates by $0.4 million.

Among the hedge funds being tracked by Insider Monkey, California-based investment firm Woodline Partners is a leading shareholder in Allogene Therapeutics, Inc. (NASDAQ:ALLO) with 5.8 million shares worth more than $66 million.

Unlike Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Meta Platforms, Inc. (NASDAQ:FB), Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the most shorted stocks right now.

14. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Number of Hedge Fund Holders: 12

Short Interest as of November 15: 46.77%

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) is a precision oncology company that engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. One of the leading product candidates for the firm is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.

At the end of the second quarter of 2022, 12 hedge funds in the database of Insider Monkey held stakes worth $270 million in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), compared to 15 in the previous quarter worth $374 million.

13. World Acceptance Corporation (NASDAQ:WRLD)

Number of Hedge Fund Holders: 9

Short Interest as of November 15: 28.01%

World Acceptance Corporation (NASDAQ:WRLD) engages in the small-loan consumer finance business. It is one of the most shorted stocks right now. On October 27, World Acceptance posted earnings for the second quarter of 2022, reporting losses per share of $0.05, beating market estimates by $0.37. The revenue over the period was $151.2 million, up 9.7% year-on-year and beating market estimates by $9.95 million.

Among the hedge funds being tracked by Insider Monkey, Beijing-based investment firm CAS Investment Partners is a leading shareholder in World Acceptance Corporation (NASDAQ:WRLD) with 755,768 shares worth more than $84.8 million.

12. Tricida, Inc. (NASDAQ:TCDA)

Number of Hedge Fund Holders: 22

Short Interest as of November 15: 40.86%

Tricida, Inc. (NASDAQ:TCDA) is a California-based pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm OrbiMed Advisors is a leading shareholder in Tricida, Inc. (NASDAQ:TCDA) with 10.2 million shares worth more than $99 million.

11. Clear Secure, Inc. (NYSE:YOU)

Number of Hedge Fund Holders: 15

Short Interest as of November 15: 23.46%

Clear Secure, Inc. (NYSE:YOU) provides a member-centric secure identity platform in the United States. It is one of the most shorted stocks right now. On August 15, Clear Secure posted earnings for the second quarter of 2022, reporting earnings per share of $0.00, beating market estimates by $0.04. The revenue over the period was $102.72 million, up 2.5% compared to the revenue over the same period last year and beating market estimates by $2.57 million.

At the end of the second quarter of 2022, 15 hedge funds in the database of Insider Monkey held stakes worth $305 million in Clear Secure, Inc. (NYSE:YOU), compared to 19 in the previous quarter worth $354.9 million.

10. AST SpaceMobile, Inc. (NASDAQ:ASTS)

Number of Hedge Fund Holders: 11

Short Interest as of November 15: 30.67%

AST SpaceMobile, Inc. (NASDAQ:ASTS) provides space-based mobile broadband services and is headquartered in Texas. The services that the company provides aim to serve users traveling in and out of areas without terrestrial mobile services on land, at sea, or in flight.

At the end of the second quarter of 2022, 11 hedge funds in the database of Insider Monkey held stakes worth $19 million in AST SpaceMobile, Inc. (NASDAQ:ASTS), the same as in the previous quarter worth $32 million.

9. Big Lots, Inc. (NYSE:BIG)

Number of Hedge Fund Holders: 14

Short Interest as of November 15: 27.58%

Big Lots, Inc. (NYSE:BIG) operates as a home discount retailer in the United States. It is one of the most shorted stocks right now. On September 15, DoorDash noted that it has formed a new partnership with Big Lots to provide on-demand delivery of all home essentials and decor products directly to the consumers’ doorsteps.

On August 24, Deutsche Bank analyst Krisztina Katai maintained a Hold rating on Big Lots, Inc. (NYSE:BIG) stock and lowered the price target to $18 from $23, noting that the reduced estimates reflect elevated inventory levels and clearing activity.

At the end of the second quarter of 2022, 14 hedge funds in the database of Insider Monkey held stakes worth $54.3 million in Big Lots, Inc. (NYSE:BIG), compared to 12 in the preceding quarter worth $63.8 million.

8. Bed Bath and Beyond Inc. (NASDAQ:BBBY)

Number of Hedge Fund Holders: 14

Short Interest as of November 15: 36.18%

Bed Bath and Beyond Inc. (NASDAQ:BBBY) operates a chain of retail stores of domestic merchandise. On October 25, officials of Bed Bath and Beyond noted that The Lynchburg Bed Bath and Beyond, located in Wards Crossing, will be closing in the coming months. On November 1, Bed Bath and Beyond announced the first private label of its BuyBuy Baby banner.

On September 30, Odeon Capital analyst Alexander Arnold upgraded Bed Bath & Beyond Inc. (NASDAQ:BBBY) stocks to Hold from Sell with an unchanged price target of $7.50.

At the end of the second quarter of 2022, 14 hedge funds in the database of Insider Monkey held stakes worth $23 million in Bed Bath and Beyond Inc. (NASDAQ:BBBY), compared to 15 in the previous quarter worth $69 million.

7. CompoSecure, Inc. (NASDAQ:CMPO)

Number of Hedge Fund Holders: 14

Short Interest as of November 15: 22.33%

CompoSecure, Inc. (NASDAQ:CMPO) manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. It is one of the most shorted stocks right now. On September 16, CompoSecure announced that its management team will participate in two upcoming investor conferences. On August 4, CompoSecure posted earnings for the second quarter of 2022, reporting earnings per share of $0.52. The revenue over the period was $97.2 million, up 55.0% compared to the revenue over the same period last year.

On October 11, JPMorgan analyst Reginald Smith initiated coverage of CompoSecure, Inc. (NASDAQ;CMPO) stocks with an Overweight rating and $10 price target, noting that company is the leading provider of premium metal payment cards, a market expected to double to roughly 60M cards issued by 2025, a $750M annualized revenue opportunity.

Among the hedge funds being tracked by Insider Monkey, London-based investment firm LMR Partners is a leading shareholder in CompoSecure, Inc. (NASDAQ:CMPO) with 1.2 million shares worth more than $6.5 million.

6. Warby Parker Inc. (NYSE:WRBY)

Number of Hedge Fund Holders: 20

Short Interest as of November 15: 27.34%

Warby Parker Inc. (NYSE:WRBY) provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. On October 21, in an interview with CNN, the CEO of Warby Parker, David Gilboa, noted that Warby Parker is looking to open hundreds of brick-and-mortar locations. The company plans to have 200 stores complete with eye exam suites by year-end.

At the end of the second quarter of 2022, 20 hedge funds in the database of Insider Monkey held stakes worth $400.3 million in Warby Parker Inc. (NYSE:WRBY), compared to 18 in the preceding quarter worth $1.2 billion.

In contrast to Amazon.com, Inc. (NASDAQ:AMZN), Microsoft Corporation (NASDAQ:MSFT), and Meta Platforms, Inc. (NASDAQ:FB), Warby Parker Inc. (NYSE:WRBY) is one of the most shorted stocks right now.

In its Q2 2022 investor letter, Polen Capital, an asset management firm, highlighted a few stocks and Warby Parker Inc. (NYSE:WRBY) was one of them. Here is what the fund said:

“Warby Parker Inc. (NYSE:WRBY) is an omnichannel retailer of prescription glasses, contacts, and sunglasses. The market’s rapid shift toward favouring profitable companies posed challenges for the company in the quarter as did weaker results which were pandemic-related.

Warby Parker is less profitable at this stage of its lifecycle as it invests in building out its retail footprint. We expect the company to be cash-flow positive within a year as it continues to benefit from scale and as retail foot traffic and productivity of the company’s retail stores return to normal as pandemic conditions ease. We may have had the opportunity to add this holding at a more ideal price. However, we remain excited about the long-term growth potential of the business, and the expected IRR.”

Click to continue reading and see 5 Most Shorted Stocks Right Now.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Insider Monkey Ads

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Published on May 15, 2026 at by Inan Dogan, PhD

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returns! Sign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on this $3 stock with 400% upside potential.
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

15 Most Shorted Stocks Right Now

Published on November 17, 2022 at 6:18 pm by Usman Kabir in Hedge Funds, News

Most Shorted Stocks Right Now

15. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

14. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

13. World Acceptance Corporation (NASDAQ:WRLD)

12. Tricida, Inc. (NASDAQ:TCDA)

11. Clear Secure, Inc. (NYSE:YOU)

10. AST SpaceMobile, Inc. (NASDAQ:ASTS)

9. Big Lots, Inc. (NYSE:BIG)

8. Bed Bath and Beyond Inc. (NASDAQ:BBBY)

7. CompoSecure, Inc. (NASDAQ:CMPO)

6. Warby Parker Inc. (NYSE:WRBY)

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Published on May 15, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

15 Most Shorted Stocks Right Now

Published on November 17, 2022 at 6:18 pm by Usman Kabir in Hedge Funds, News

Share

Most Shorted Stocks Right Now

15. Allogene Therapeutics, Inc. (NASDAQ:ALLO)

14. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

13. World Acceptance Corporation (NASDAQ:WRLD)

12. Tricida, Inc. (NASDAQ:TCDA)

11. Clear Secure, Inc. (NYSE:YOU)

10. AST SpaceMobile, Inc. (NASDAQ:ASTS)

9. Big Lots, Inc. (NYSE:BIG)

8. Bed Bath and Beyond Inc. (NASDAQ:BBBY)

7. CompoSecure, Inc. (NASDAQ:CMPO)

6. Warby Parker Inc. (NYSE:WRBY)

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on May 16, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Published on May 15, 2026 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: